An Avalere survey found health plans are more frequently working with drug and medical device companies to link reimbursement to clinical, quality, utilization or financial outcomes. Payers are targeting cardiovascular disease, infectious diseases and cancers most often but also are interested in orthopedics, diabetes and other endocrine disorders.
Insurers push deeper into outcomes-based contracting
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.